Cold

Main information

  • Trade name:
  • Cold treatment spray
  • Class:
  • Class 1
  • Medicine domain:
  • Humans
  • Medicine type:
  • Medical device

Documents

Localization

  • Available in:
  • Cold treatment spray
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 220435
  • Last update:
  • 08-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

220435

Ice Medicals Australasia Pty Ltd - Cold treatment spray

ARTG entry for

Medical Device Included Class 1

Sponsor

Ice Medicals Australasia Pty Ltd

Postal Address

Level 8 / 275 Alfred Street,North Sydney, NSW, 2060

Australia

ARTG Start Date

25/02/2014

Product category

Medical Device Class 1

Status

Active

Approval area

Medical Devices

Conditions

- The inclusion of the kind of device in the ARTG is subject to compliance with all conditions placed or imposed on the ARTG entry. Refer Part 4-5,

Division 2 (Conditions) of the Therapeutic Goods Act 1989 and Part 5, Division 5.2 (Conditions) of the Therapeutic Goods (Medical Devices) Regulations

2002 for relevant information.

- Breaching conditions of the inclusion related to the device of the kind may lead to suspension or cancellation of the ARTG entry; may be a criminal

offence; and civil penalties may apply.

Manufacturers

Name

Address

Liquid Ice AG

74 Zugerstrasse

Zugerstrasse, Baar, 6341

Switzerland

Products

1. Cold treatment spray

Product Type

Single Device Product

Effective date

25/02/2014

GMDN

46557 Cold treatment spray

Intended purpose

A liquid in a container that is vaporised when dispensed for application to the body

surface/garment/bandage to provide a cooling effect for

surface and underlying tissues. It is used to reduce pain and swelling typically from sports injuries. This

product can also be used as a

cold-compression treatment when applied via bandage.

Specific Conditions

No Specific Conditions included on Record

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 1 of

Produced at 10.11.2017 at 04:05:15 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

26-10-2018

Multi-country outbreak of Listeria monocytogenes sequence type 8 infections linked to consumption of salmon products

Multi-country outbreak of Listeria monocytogenes sequence type 8 infections linked to consumption of salmon products

Published on: Thu, 25 Oct 2018 00:00:00 +0200 A multi-country outbreak of 12 listeriosis cases caused by Listeria monocytogenes sequence type (ST) 8 has been identified through whole genome sequencing (WGS) analysis in three EU/EEA countries: Denmark (6 cases), Germany (5) and France (1). Four of these cases have died due to or with the disease. It is likely that the extent of this outbreak has been underestimated since the outbreak was identified through sequencing and only a subset of the EU/EEA count...

Europe - EFSA - European Food Safety Authority Publications

14-3-2018

Is It a Cold or the Flu? Prevention, Symptoms, Treatments

Is It a Cold or the Flu? Prevention, Symptoms, Treatments

How to tell if you have a cold or the flu, and when to seek medical care.

FDA - U.S. Food and Drug Administration

16-3-2015

New management at the DHMA

New management at the DHMA

As from 13 March 2015, Jakob Cold has been appointed Acting Director General of the Danish Health and Medicines Authority. Anne-Marie Vangsted will continue as Director with special responsibility for the DHMA's supervision.

Danish Medicines Agency

There are no news related to this product.